Skip to content

Black Diamond Therapeutics, Inc.

BDTX · XNAS

CIK 1701541fmd_02YAWNMTW6C3H8162GRM6QV6SAManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2018 to Sep 30, 2026, 35 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading